Identifying Staphylococcus aureus Using Different Agar Plates

No single agar plate identifies Staphylococcus aureus with perfect reliability. Labs choose from a toolkit of selective and differential media, each exploiting a different biochemical trait of the organism, and the best choice depends on the specimen type, the clinical question, and the resources available. Blood agar, mannitol salt agar, Baird-Parker agar, DNase agar, and several newer chromogenic formulations all play distinct roles, and each comes with trade-offs in sensitivity, specificity, turnaround time, and cost.

Blood Agar and Hemolysis Patterns

Sheep blood agar is one of the most widely used general-purpose media in clinical microbiology, and it gives a first visual clue about whether a colony might be S. aureus. The organism produces hemolysins that lyse red blood cells, creating a clear zone around colonies known as beta-hemolysis. That clear halo, combined with the golden pigment many strains produce, is often the earliest hint a technologist has that S. aureus is present. But blood agar is not selective. Dozens of other bacteria grow on it, and beta-hemolysis is not unique to S. aureus. It serves as a starting point, not a confirmation.

Even the hemolytic pattern itself is not completely reliable. Researchers have documented S. aureus strains with an incomplete hemolytic phenotype isolated from clinical samples, where the expected clear zone appears partial or ambiguous depending on the manufacturer of the blood agar plates used.¹ A separate study of clinical isolates found that both methicillin-resistant and methicillin-susceptible S. aureus strains exhibited only beta- and gamma-hemolytic phenotypes, with gamma-hemolysis meaning no visible hemolysis at all.² A non-hemolytic S. aureus colony on blood agar looks unremarkable and could easily be dismissed, which is why labs rarely rely on blood agar alone for identification.

Mannitol Salt Agar

Mannitol salt agar (MSA) is probably the most familiar selective and differential medium for S. aureus in teaching labs and resource-limited clinical settings. It contains a high concentration of sodium chloride, typically around 7.5%, which inhibits most bacteria but allows staphylococci to grow. The differential component is mannitol, a sugar alcohol. S. aureus ferments mannitol, producing acid that turns the phenol red indicator in the agar from pink to yellow. A yellow zone surrounding colonies on MSA is the classic presumptive positive result.

This combination of salt tolerance and mannitol fermentation makes MSA useful as a rapid, inexpensive screen. In specimens from cystic fibrosis patients, for example, yellow colonies on MSA at quantities above a low threshold could be reported as S. aureus, reducing time to identification and cutting costs by eliminating additional confirmatory steps.³ Antimicrobial susceptibility testing can also be performed directly from MSA isolates, saving a subculture step.

The problem is that MSA is not as specific as it looks. Some coagulase-negative staphylococci (CoNS), which are generally less pathogenic relatives of S. aureus, can also grow on MSA and ferment mannitol, producing yellow colonies that look identical to S. aureus.⁴ In labs where resources limit the number of confirmatory tests available, this overlap can lead to false-positive reports. MSA tells you something is a staphylococcus that ferments mannitol, but a follow-up coagulase or molecular test is needed to confirm that “something” is truly S. aureus.

Baird-Parker Agar and Food Safety Applications

In food microbiology, the go-to medium for S. aureus is Baird-Parker agar, which uses potassium tellurite and lithium chloride as selective agents and egg yolk as the differential ingredient. S. aureus colonies appear black or dark gray on this medium because they reduce tellurite, and the egg yolk allows detection of two lipolytic reactions: a lecithinase reaction that produces a zone of precipitate surrounding colonies, and a lipase reaction that creates an iridescent “pearly layer” visible under reflected light.⁵ The combination of black colonies with clearing zones is distinctive and, in head-to-head comparisons for food testing, Baird-Parker agar was judged the best medium when recovery rates, colony reactions, and counting errors were all considered.⁶

An alternative used in food testing is Rabbit Plasma Fibrinogen agar (RPFA), which detects coagulase activity directly on the plate: S. aureus colonies develop a halo of coagulated fibrinogen. Comparative studies of raw milk and soft cheese samples found that RPFA and the Petrifilm Staph Express system correlated well with coagulase- and thermonuclease-positive colony counts.⁷ One practical caution with fibrinogen-based media is that the potassium tellurite concentration recommended for Baird-Parker agar can be too inhibitory for some S. aureus strains; reducing tellurite four-fold has been shown to improve recovery in these cases.⁸

DNase Agar as a Confirmatory Tool

S. aureus produces the enzyme deoxyribonuclease (DNase), which breaks down DNA. DNase agar exploits this by incorporating DNA and either methyl green or toluidine blue into the medium. After incubation, the plate is flooded with hydrochloric acid. Where the organism has degraded the DNA, a clear zone appears around the colonies against the opaque background of intact DNA.⁹ When a methyl green indicator is used instead, S. aureus colonies produce a colorless zone as the dye is released from the degraded DNA.¹⁰

DNase testing is generally used as a confirmatory step rather than a primary isolation method. A classic evaluation of 520 clinical isolates found that while the vast majority of confirmed S. aureus strains produced DNase, three isolates that were clearly S. aureus by coagulase and thermostable nuclease testing failed the DNase test.¹¹ That is a small false-negative rate, but it reinforces the general principle that no single phenotypic test catches every strain.

Chromogenic Media

Chromogenic agar represents a significant step forward in speed and ease of identification. These media contain synthetic enzyme substrates linked to chromogens, which are colorless compounds that release a visible dye when cleaved by a specific bacterial enzyme. For S. aureus, the target enzyme is alpha-glucosidase. When S. aureus grows on a medium such as S. aureus ID (bioMérieux), it produces distinctively colored colonies, typically green, while other organisms either fail to grow or produce a different color.¹² The principle extends to other pathogens as well, with different chromogenic substrates targeting different species-specific enzymes.¹³

In practice, chromogenic agars have outperformed MSA for detecting S. aureus. CHROMagar Staph aureus detected S. aureus from nasal swabs with 98% sensitivity compared to 84.3% for MSA.¹⁴ In a study of respiratory samples, which tend to be heavily contaminated with mixed flora, BBL CHROMagar Staph aureus achieved sensitivity and specificity of 99.5% and 98%, and recovered a dozen S. aureus isolates that conventional media missed entirely.¹⁵ That said, chromogenic media are not foolproof: in that same respiratory study, nine non-S. aureus organisms produced the suspicious mauve color, including Staphylococcus lugdunensis, S. epidermidis, and even Corynebacterium species.

MRSA-Specific Screening Plates

Identifying S. aureus is only half the clinical question when methicillin resistance is a concern. Several agar formulations combine S. aureus selectivity with an antibiotic to screen specifically for MRSA. The simplest approach adds an antibiotic to MSA. Adding cefoxitin at 4 mg/L to mannitol salt agar allowed growth of about 97% of confirmed MRSA strains while inhibiting 100% of methicillin-susceptible strains in one well-characterized collection.¹⁶ Cefoxitin has largely replaced oxacillin in these formulations because it is a stronger inducer of the resistance mechanism and better at catching strains that hyper-produce penicillinase, which can fool oxacillin-based media.¹⁷

Chromogenic MRSA agars take this a step further by combining antibiotic selection with a color indicator for S. aureus. In a prospective comparison, MRSASelect agar achieved 97.3% sensitivity and 99.8% specificity, outperforming CHROMagar MRSA and both oxacillin- and cefoxitin-supplemented MSA formulations in specificity.¹⁸ The practical advantage is significant: a single plate, read the next morning, can tell an infection control team both “this is S. aureus” and “it is methicillin-resistant.”

When the Plates Give Wrong Answers

Every agar-based identification method assumes that the target organism will behave in the expected way, and atypical strains exist for nearly every trait labs test for. Mannitol fermentation is the backbone of MSA-based identification, yet a study of 1,829 S. aureus strains found that about 2.2% did not ferment mannitol and would appear as negative on MSA.¹⁹ Mannitol-negative MRSA strains have been documented in clinical settings and were even misidentified by a commercial automated system as a different species entirely, Staphylococcus lugdunensis.²⁰

Mucoid variants of S. aureus present another diagnostic trap. These strains produce an unusually heavy capsule that interferes with the coagulase test, the DNase test, and mannitol fermentation simultaneously. In one investigation, ten mucoid S. aureus strains were sent to hospital microbiology laboratories, and all were misidentified when tested by the standard combination of coagulase, DNase, and mannitol criteria.²¹ The researchers concluded that reliance on a few key characteristics, rather than thorough characterization, created a real risk of misidentifying unusual isolates. In modern labs, molecular confirmation through PCR targeting the nuc gene (encoding thermostable nuclease) or the mecA gene (for methicillin resistance) resolves ambiguous cases, but not every lab has ready access to molecular methods.

Enrichment Broth Before Plating

The sensitivity of any agar plate depends partly on how many organisms are present in the sample when it is streaked. When bacterial counts are low, as they often are in surveillance swabs from carriers, incubating the swab in an enrichment broth before plating onto selective agar can dramatically increase detection. In a Swedish study, enrichment broth increased the proportion of S. aureus-positive samples by 46%, with the largest gains seen in vaginal samples, infant nasal swabs, and adult throat swabs.²²

For MRSA screening specifically, an evaluation of HIV-infected outpatients found that enrichment broth detected 95% of MRSA-positive specimens, compared to 82% for chromogenic agar and 76% for MSA when plates were inoculated directly.²³ LIM broth, a cost-effective enrichment medium, achieved 100% MRSA detection when combined with MSA in another study of surveillance specimens, catching five additional MRSA isolates that direct plating missed.²⁴ The trade-off is time: enrichment adds a day to the process, which matters in settings where rapid results guide patient isolation decisions.

Environmental and Veterinary Contexts

Agar plate selection is not just a clinical laboratory concern. Infection control teams swab hospital surfaces, bedrails, keyboards, and shared equipment to track MRSA transmission, and the choice of sampling method and plating medium affects what they find. A comparison of five environmental sampling methods concluded that both contact plates (RODAC plates pressed directly against a surface) and moistened swabs provided adequate S. aureus recovery from both porous and non-porous surfaces.²⁵ For large-scale epidemiologic studies, the protocol must balance cost, time to results, and the physical shape of the surface being sampled.

In veterinary medicine, S. aureus is a major cause of bovine mastitis, and the diagnostic challenge mirrors what human clinical labs face. An evaluation of four media for isolating S. aureus from mastitis milk samples tested salt-mannitol agar, Staphylococcus-110 agar, CHROMagar Staph aureus, and sheep blood agar side by side.²⁶ The same general patterns hold: chromogenic media tend to offer better specificity, while traditional salt-based and blood-based media remain the workhorses where budgets are tight. One wrinkle with animal strains is that lecithinase activity on Baird-Parker medium varies by host origin, with bovine isolates showing a lower percentage of positive lecithinase reactions than human isolates.⁵ This means a plate that works well for identifying S. aureus from a human wound swab may perform less reliably when applied to a milk sample from a dairy cow.

Choosing the Right Plate for the Job

There is no universal “best” agar plate for S. aureus. The decision tree is shaped by the question being asked and the constraints of the setting. For everyday clinical work with respiratory or wound cultures, a chromogenic agar gives the fastest, most reliable presumptive identification, especially in polymicrobial samples where S. aureus might otherwise be overlooked among the background flora. For MRSA surveillance programs, a chromogenic MRSA agar or cefoxitin-supplemented MSA with enrichment broth offers the highest detection rate. For food safety testing, Baird-Parker agar remains the international standard, with rabbit plasma fibrinogen agar as a strong alternative for coagulase detection on the plate itself.

In resource-limited settings, MSA with a follow-up coagulase test is a reasonable and cost-effective approach, but technologists need to be aware of the CoNS overlap and the roughly 2% of S. aureus strains that will not ferment mannitol. DNase agar serves best as a second-line confirmatory test rather than a primary screen. Blood agar is indispensable as a general-purpose culture medium but is too nonspecific to serve as the sole basis for S. aureus identification. And whenever results from any plate look ambiguous, whether a colony color is borderline, a coagulase test is weakly positive, or a hemolytic pattern is unusual, the safe practice is to confirm with a second method rather than report from a single phenotypic test. Mucoid variants and mannitol-negative strains are uncommon, but uncommon is not the same as negligible when a missed S. aureus diagnosis can mean the wrong antibiotic or a missed infection control intervention.